By: Dulan Lokuwithana, SA News Editor on Seeking Alpha A recently published study found that each cannabis legalization event that happened between 1996 and 2018 in the U.S. caused generic and branded pharma companies to lose ~$10B in market cap on average, implying a sales impact of $3B. Scientists argue that their findings, that highlight the market’s recognition of cannabis … [Read more...] about Cannabis legalization wiped off ~$10B market cap in pharma sector – study